Navigation Links
Oncolytics Biotech Inc. Collaborators Present Reovirus and Melanoma Research at EORTC-NCI-AACR Symposium
Date:10/23/2008

is jointly organized by the European Organization for Research and Treatment of Cancer (EORTC), the U.S. National Cancer Institute (NCI) and the American Association for Cancer Research (AACR).

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the implication of the materials presented at this meeting with respect to REOLYSIN(R), the Company's expectations related to the results of trials investigating delivery of REOLYSIN(R), and the Company's belief as to the potential of REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue research and development projects, the efficacy of REOLYSIN(R) as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN(R), uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...YORK, Dec. 2 Reportlinker.com anno...le in its catalogue: ,, Neurostimulation - A G...linker.com/p0164232/Neurostimulation---A-Global-Ma...lation market stands enthused by the growing base ...-related diseases such as, Parkinson,s, and Alzhei...
(Date:12/2/2009)... Calif., Dec. 2 Peregrin...orted completion of patient enrollment in a dose c... patients with relapsed glioblastoma multiforme (G...s a targeted monoclonal antibody linked to a radio...nt for GBM. Cotara specifically targets cells at ...
(Date:12/2/2009)... JERUSALEM, Israel, December 2 Gam...ating the preclinical (animal study) safety and,ef...chnology from Weill,Cornell Medical College and Ga... inherited anemias such as Cooley,s Anemia. ,...ogies to expand, ex vivo,populations of stem/prog...
(Date:12/2/2009)...NGHAI, Dec. 2 /PRNewswire-Asia/ -- The world is go...rmoil and uncertainty is part of many,businesses a...ry has been,relatively immune to the economic down..., During the midst of the difficult times th...hnson inaugurated an R&D center in Shanghai, t...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3
...7 Earnings Conference Call Thursday, November 8, 2... FRAZER, Pa., Oct. 1 Cephalon, Inc. (Nasdaq:,CEP...nference call covering,third quarter 2007 results ... November 8, 2007 Schedule, ...d by PRNewswire 4:50 p.m. EST To participate in...
...t. 1 A highly sensitive, easy-to-use,test that ac...) was,selected as the Best New Veterinary Product ... BoVir(R) BVDV real time PCR test was selected for...udging panel representing,members of the global co...ssionals. The award was presented September 25, 20...
...ment - Guaranteed Purchase Requi...Manufacturing of DaySpring Core ...nge Between $4.4M-7M Over Five Years, IRVING, Tex...eets: CARN) ( http://www.CarringtonLabs.com ),toda...nced multi-year,supply and distribution term sheet...
Other Biology Technology:BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards 2BoVir(R) Named Best New Veterinary Diagnostics Product in International Animal Pharm Awards 3Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market 2Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market 3
(Date:12/2/2009)...ef, peanut butter, and other foods have done more ... safety. They also are quietly fueling a boom in t... new food safety regulations. That,s the topic of ...Chemical & Engineering News , (C&EN) ACS, weekly n...sley and Senior Correspondent Marc Reisch point ou...
(Date:12/2/2009)...ised of undergraduate students from Stevens Instit...onal poster contest hosted by the International So...he annual contest highlights the research conducte...SPE Annual Meeting in San Diego, Calif. , The wi...iciate Ligament Tensioning Device," was presented ...
(Date:12/2/2009)...it have a higher IQ and are more likely to go on t...t at the Sahlgrenska Academy and Sahlgrenska Unive...ay in the prestigious Proceedings of the National... 1.2 million Swedish men doing military service wh...oup analysed the results of both physical and IQ t...
Breaking Biology News(10 mins):Young adults who exercise get higher IQ 2Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 57936 1Former NFL Quarterback to Speak at Local Nonprofit Fundraising Event 57936 2ACUVUE 28R 29 Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 57931 1ACUVUE 28R 29 Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 57931 2ACUVUE 28R 29 Brand Contact Lenses Gives Movie Fans a Chance to Win a Hometown Screening of WHIP IT 57931 3CutisPharma Launches New Prescription Mouthwash Kit Adding to Product Line 57928 1CutisPharma Launches New Prescription Mouthwash Kit Adding to Product Line 57928 2
... (Great Neck, NY, Sept. 2, 2008) People concerne...taking on their families and communities will have...erts on what is known to-date about the causes, sy...sion, bipolar disorder, anxiety, schizophrenia and...atments. , In an unprecedented event called Healt...
... Dr Dick James from the University,s Department o...gists explaining how social network analysis, a me...nteractions among people, can be used to study soc...tionally, students of animal behaviour have looked...or at global behaviours of populations; however us...
..., Scientists at Penn State have developed a new c...o understand how life began on Earth. The team,s ... histories of proteins all the way back to either ...d for all over which of these life forms came firs... of this method," said Randen Patterson, a Penn St...
Other Biology News:Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 2Healthy Minds Across America features 48 public forums on mental health research, Sept. 14 3Scientists develop new method to investigate origin of life 2Scientists develop new method to investigate origin of life 3
...loning of BAC (100+kb), fosmid (40kb), and large p...lity than any othe BAC vector. On command 20-50 fo...ombinant DNA purification. Available with blue-whi...RT VC) vectors for the highest insert stability. K...
ApoStat Intracellular Caspase Detection (FITC-VD-FMK) from R&D Systems
Mouse Anti-Rat RT1Bu (Class II Polymorphic) Monoclonal Antibody, Biotin Conjugated from AbD Serotec
Mouse Anti-Guinea Pig T-Cells, Pan Monoclonal Antibody, FITC Conjugated from AbD Serotec
Biology Products: